February 14, 2012
Buprenorphine Treatment During Pregnancy
Marjorie C. Meyer, M.D.
Associate Professor, OB/GYN
Director, Division of Maternal Fetal Medicine
University of Vermont School of Medicine
The webinar focuses on pregnancy and the initiation and maintenance of buprenorphine for the treatment of opioid dependence during pregnancy. Dr. Meyer discusses the physiology of pregnancy; risks/benefits of buprenorphine vs methadone; risks of induction during pregnancy; the team recommended for treatment of pregnant women; dose adjustments during pregnancy; and pain control during labor and delivery.
Please click here to access Dr. Meyer’s PowerPoint presentation.
We value your feedback and invite your comments. Please email us at email@example.com to provide your comments or suggestions for future webinar topics.
NOTE: Archived sessions can be accessed in the upper left corner of this page under Inside this Section.
Adobe Flash Player is required to view this video. If you experience trouble, please confirm you have the most current version of Adobe Flash Player. The latest version of Adobe Flash Player is available as a free download